Prenetics (PRE) CEO buys 20,118 shares in open-market trade

Prenetics Global Limited (PRE) reported that its Chief Executive Officer and co-founder, Danny Sheng Wu Yeung, bought additional company stock on the open market.

Rhea-AI Filing Summary

Prenetics Global Limited (PRE) reported that its Chief Executive Officer and co-founder, Danny Sheng Wu Yeung, bought additional company stock on the open market. On November 18, 2025, he purchased 20,118 Class A Ordinary Shares at a price of $12.02 per share, for a total of about $242,000. Following this transaction, his holdings in the company’s Class A Ordinary Shares increased to 76,412, signaling a higher personal stake in Prenetics’ future performance.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Prenetics Global Limited (PRE) disclose in this Form 6-K?

Prenetics Global Limited disclosed that its Chief Executive Officer and co-founder, Danny Sheng Wu Yeung, purchased additional Class A Ordinary Shares in an open market transaction.

How many Prenetics (PRE) shares did the CEO buy and at what price?

The CEO bought 20,118 Class A Ordinary Shares of Prenetics at a price of $12.02 per share in an open market purchase.

What was the total dollar amount of the Prenetics CEO share purchase?

The total purchase price for the CEO’s transaction was approximately $242,000 based on 20,118 shares at $12.02 per share.

What are the CEO’s total holdings in Prenetics Class A Ordinary Shares after the purchase?

After the transaction, CEO Danny Sheng Wu Yeung holds a total of 76,412 Class A Ordinary Shares of Prenetics Global Limited.

Was the Prenetics CEO share purchase an open market transaction?

Yes. The filing states that the 20,118 Class A Ordinary Shares were purchased in the open market at $12.02 per share.

Who signed the Form 6-K for Prenetics Global Limited (PRE)?

The Form 6-K was signed on behalf of Prenetics Global Limited by Lo Hoi Chun, the company’s Chief Financial Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/19/2025 - 07:00 AM EST Learn about SEC filing dates

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE
13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2025

Commission File Number 001-41401

Prenetics Global Limited

11401 Granite St. Charlotte, NC 28273 USA Unit 703-706, K11 Atelier 728 King’s Road, Quarry Bay Hong Kong

(Addresses of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.  Form 20-F  Form 40-F 

EXPLANATORY NOTE

Prenetics Global Limited (the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, furnishes this Form 6-K to announce that on November 18, 2025 its Chief Executive Officer and co-founder, Danny Sheng Wu Yeung, purchased 20,118 shares of the Company's Class A Ordinary Shares at a price of $12.02 per share in the open market for a total purchase price of approximately $242,000, bringing his total holdings of Class A Ordinary Shares to 76,412.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

			Prenetics Global Limited
			By:			/s/ Lo Hoi Chun
			Name:			Lo Hoi Chun
			Title:			Chief Financial Officer
Date: November 19, 2025